Publications

  1. Qiao J, Wang H, Kottke T, Diaz RM, Willmon C, Hudacek A, Thompson J, Parato K, Bell J, Naik J, Chester J, Selby P, Harrington K, Melcher A, Vile RG. Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors. Gene Ther. 2008 Apr; 15(8):604-16. Epub 2008 Feb 28.
    View PubMed
  2. Qiao J, Ghani K, Caruso M. Diphtheria toxin mutant CRM197 is an inhibitor of protein synthesis that induces cellular toxicity. Toxicon. 2008 Mar 1; 51(3):473-7. Epub 2007 Oct 01.
    View PubMed
  3. Qiao J, Wang H, Kottke T, White C, Twigger K, Diaz RM, Thompson J, Selby P, de Bono J, Melcher A, Pandha H, Coffey M, Vile R, Harrington K. Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus. Clin Cancer Res. 2008 Jan 1; 14(1):259-69.
    View PubMed
  4. Qiao J, Kottke T, Willmon C, Galivo F, Wongthida P, Diaz RM, Thompson J, Ryno P, Barber GN, Chester J, Selby P, Harrington K, Melcher A, Vile RG. Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nat Med. 2008 Jan; 14(1):37-44. Epub 2007 Dec 09.
    View PubMed
  5. Sanchez-Perez L, Gough M, Qiao J, Thanarajasingam U, Kottke T, Ahmed A, Thompson JM, Maria Diaz R, Vile RG. Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells. Gene Ther. 2007 Jul; 14(13):998-1009. Epub 2007 Apr 19.
    View PubMed
  6. Diaz RM, Galivo F, Kottke T, Wongthida P, Qiao J, Thompson J, Valdes M, Barber G, Vile RG. Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus. Cancer Res. 2007 Mar 15; 67(6):2840-8.
    View PubMed
  7. Thanarajasingam U, Sanz L, Diaz R, Qiao J, Sanchez-Perez L, Kottke T, Thompson J, Chester J, Vile RG. Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy. Cancer Res. 2007 Jan 1; 67(1):300-8.
    View PubMed
  8. Qiao J, Moreno J, Sanchez-Perez L, Kottke T, Thompson J, Caruso M, Diaz RM, Vile R. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Gene Ther. 2006 Oct; 13(20):1457-70. Epub 2006 May 25.
    View PubMed
  9. Kottke T, Qiao J, Diaz RM, Ahmed A, Vroman B, Thompson J, Sanchez-Perez L, Vile R. The perforin-dependent immunological synapse allows T-cell activation-dependent tumor targeting by MLV vector particles. Gene Ther. 2006 Aug; 13(15):1166-77. Epub 2006 Apr 20.
    View PubMed
  10. Roy V, Qiao J, de Campos-Lima P, Caruso M. Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase. Gene Ther. 2005 Oct 14; 12(2):169-76.
    View PubMed
  11. Cole C, Qiao J, Kottke T, Diaz RM, Ahmed A, Sanchez-Perez L, Brunn G, Thompson J, Chester J, Vile RG. Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells. Nat Med. 2005 Oct; 11(10):1073-81. Epub 2005 Sep 18.
    View PubMed
  12. Sanz L, Qiao J, Vile RG, Alvarez-Vallina L. Antibody engineering, virus retargeting and cellular immunotherapy: one ring to rule them all? Curr Gene Ther. 2005 Feb; 5(1):63-70.
    View PubMed
  13. Germain E, Roulin VG, Qiao J, de Campos Lima PO, Caruso M. RD114-pseudotyped retroviral vectors kill cancer cells by syncytium formation and enhance the cytotoxic effect of the TK/GCV gene therapy strategy. J Gene Med. 2005; 7(4):389-97.
    View PubMed
  14. Qiao J, Diaz RM, Vile RG. Success for gene therapy: render unto Caesar that which is Caesar's. Genome Biol. 2004; 5(8):237. Epub 2004 Jul 29.
    View PubMed
  15. Qiao J, Roy V, Giard MH, Caruso M. High translation efficiency is mediated by the Encephalomyocarditis virus IRES if the natural sequence surrounding the 11th AUG is retained. Hum Gene Ther. 2002 May 1; 13(7):881-7.
  16. Qiao J, Doubrovin M, Sauter BV, Huang Y, Guo ZS, Balatoni J, Akhurst T, Blasberg RG, Tjuvaiev JG, Chen SH, Woo SL. Tumor-Specific transcriptional targeting of suicide gene therapy. Gene Ther. 2002 Feb; 9(3):168-75.
    View PubMed
  17. Qiao J, Caruso M. PG13 packaging cells produc high-titer recombinant retroviruses carrying a diphtheria toxin mutant which kills cancer cells. J Virol. 2002; 76(14):7343-48.
  18. Qiao J, Black ME, Caruso M. Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carring a herpes simplex virus thymidine kinase gene mutant. Hum Gene Ther. 2000 Jul 20; 11(11):1569-76.
  19. Martinet O, Ermekova V, Qiao JQ, Sauter B, Mandeli J, Chen L, Chen SH. Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model. J Natl Cancer Inst. 2000 Jun 7; 92(11):931-6.
    View PubMed
  20. Qiao J, Chen SH, Pham-Nguyen KB, Mandeli J, Woo SL. Construction and characterization of recombinant adenoviral vector expressing human interleukin -12. Cancer Gene Ther. 1999 Jul-Aug; 6(4):373-9.
  21. Yan Z, Qiao J, Gong H, Hou Y. A novel liver-directed gene delivery system using an autonomously replicating vector specifically expressed in AFP positive hepatoma cells. Sci China C Life Sci. 1998 Feb; 41(1):80-6.
  22. Qiao J, Qian Z. The study on system of targeted gene transfer in gene therapy for cancer. Chin J Cancer Biother. 1998.
  23. Qiao J, Yan Z, Gong H, Hou Y. Experimental study on a new targetable gene delivery system with a Epstein-Barr virus based expression vector in vivo. Chinese Journal of Virology. 1997; 13(4).
  24. Yan Z, Qiao J, Gong H, Hou Y. The specific and autonomously replicating expression system in human hepatoma cell line. Science in China. 1997; 27(4).
  25. Yan Z, Qiao J, Gong H, Wang H, Li Y, Hou Y. The construction of a novel hepatocyte targeted and autonomously replicated gene delivery system with an Epstein-Barr virus based expression vector. Chinese Journal of Virology. 1997; 13(2).
  26. Qiao J, Qian Z. A study on the Active Immunoprotection of Newcastle Disease Virus (NDV) Modified Tumor Cell Vaccine (TCV) against a Murine Uterocervical Tumor Model U14. Biotherapy. 1994; 8(3).
  27. Qiao J, Qian Z. Active specific immunotherapy in Cancer. Overseas Medicine Section of Cancer. 1994; 21(2).
  28. Qiao J, Qian Z. A study on the immunoprotection of tumor cell vaccine. Chinese Journal of Immunology. 1993; 9(65).